Two-part Safety, Tolerability, Pharmacodynamic and -Kinetic Study of Inhaled AZD8871 in Asthmatic and COPD Subjects

Clinical trial NCT02573155 · COMPLETED

Trial details

NCT number: NCT02573155
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Asthma (Part 1)COPD (Part 2)

Start date: 2015-10-01
Primary completion: 2016-08-01
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.